Talaris Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TALS and buy or sell other stocks, ETFs, and their options commission-free!About TALS
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006.
CEOSandeep C. Kulkarni, MD
CEOSandeep C. Kulkarni, MD
Employees74
Employees74
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2021
Founded2021
Employees74
Employees74
TALS Key Statistics
Market cap31.03M
Market cap31.03M
Price-Earnings ratio-5.18
Price-Earnings ratio-5.18
Dividend yield—
Dividend yield—
Average volume400.40K
Average volume400.40K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$29.79
52 Week high$29.79
52 Week low$11.56
52 Week low$11.56
People also own
Based on the portfolios of people who own TALS. This list is generated using Robinhood data, and it’s not a recommendation.